The Efficacy of Oral Everolimus in Patients With Neovascular Age-related Macular Degeneration

NCT00857259 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Choroidal Neo-Vascular Age-onset Macular Degeneration
Age-related Macular Degeneration

Interventions

DRUG: Everolimus
DRUG: Ranibizumab

Sponsor

Novartis Pharmaceuticals